Results 111 to 120 of about 9,369 (213)

Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea [PDF]

, 2012
The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMérieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.
이경원
core  

Data Files for Quantum Mechanical Simulations of Cytosine and Flucytosine using ORCA [PDF]

<p>This entry includes input and output files for performing quantum mechanical simulations of cytosine and flucytosine using HF, DFT and MP2 methods with different basiss sets using ORCA. </p ...
Kucukkal, Tugba, Monsurat, Lawal
core   +1 more source

Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study

Drug Design, Development and Therapy, 2015
Heba F Salem,1 Sayed M Ahmed,2 Ashraf E Hassaballah,3 Mahmoud M Omar1,4 1Department of Pharmaceutics and Industrial Pharmacy, Beni-suef University, 2Department of Industrial Pharmacy, Assiut University, 3Department of Clinical Pathology, Faculty of ...
Salem HF, Ahmed SM, Hassaballah AE, Omar MM   +3 more
doaj  

Urosepsis by multidrug-resistant <i>Nakaseomyces glabratus</i> with non-functional Erg3 and Erg11-do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal? [PDF]

mBio
Carolus H, Biriukov V, Vreys J, Lobo Romero C, Herrera Avila JP, Vergauwen R, Sofras D, Nysten J, Vanreppelen G, Vinken L, Britto Xavier B, Gabaldón T, Lagrou K, Naesens R, Van Dijck P.   +14 more
europepmc   +1 more source

Comparative risk of arrhythmias associated with systemic antifungal agents: a disproportionality analysis of the FAERS database. [PDF]

Front Pharmacol
Yang X, Li H, Liu K, Kong L.
europepmc   +1 more source

Shifting Epidemiology and Antifungal Susceptibility Patterns of Clinical Fungal Isolates in an Intensive Care Unit (ICU) from Bucharest, Romania: A Retrospective Observational Study. [PDF]

Antibiotics (Basel)
Solomon MP, Mahler B, Popescu O, Ditu LM, Gheorghe-Barbu I, Chivu LI, Manolescu LSC.   +6 more
europepmc   +1 more source

Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial. [PDF]

Clin Infect Dis
Rutakingirwa MK, Skipper CP, Dai B, Wele A, Namombwe S, Mugabi T, Ndyetukira JF, Sadiq A, Kabahubya M, Chemusto L, Ahimbisibwe C, Nabbale S, Kandole TK, Muyise RCB, Kagimu E, Luggya T, Mulungi J, Jjunju S, Nicol MR, Stott KE, Kwizera R, Meya DB, Boulware DR, McHale TC, FLOOR trial team .   +24 more
europepmc   +1 more source

Cryptococcal Osteomyelitis in a Virally Suppressed Adolescent Living With HIV: A Case Report. [PDF]

Case Rep Infect Dis
Mandikiyana Chirimuta LA, Rambanapasi C, Musorowegomo D, Nyatanga G, Mapfumo A, Chikati EF.   +5 more
europepmc   +1 more source

SAHCS Guideline for the prevention, diagnosis and management of cryptococcal disease among persons living with HIV: Update to induction treatment for cryptococcal meningitis. [PDF]

South Afr J HIV Med
Govender NP, Meintjes G, Falconer J, Murphy K, Nel J, Rabie H, Frigati L, Reddy DL, Dawood H, Variava E, Potgieter S, Boyles T, Stacey SL, Mangena P, Madua MC, Wattrus C, Moosa MS.   +16 more
europepmc   +1 more source

Basal ganglia cryptococcomas presenting as parkinsonism in an immunocompetent patient. [PDF]

IDCases
Ruiz LLP, Arévalo-Carvajal PF, Agudelo LG, Mariño DA.   +3 more
europepmc   +1 more source